Electromedical Technologies, Inc (EMED)
2024-09-30 | 2024-06-30 | |||
|---|---|---|---|---|
| Net sales | 42,526 | 237,645 | ||
| Cost of sales | 11,881 | 64,390 | ||
| Us-gaap_grossprofit | 30,645 | 173,255 | ||
| Selling, general and administrative expenses | 411,683 | 425,100 | ||
| Us-gaap_operatingincomeloss | -381,038 | -251,845 | ||
| Change in fair value of derivative liabilities | -338,698 | - | ||
| Interest expense | - | 58,301 | ||
| Derivative, gain (loss) on derivative, net | - | 121,319 | ||
| Amount of income expenses related to other non operating activities | - | 82,624 | ||
| The amount of change in fair value of derivative liabilities | - | -337,439 | ||
| Us-gaap_othernonoperatingincomeexpense | 3,521 | 483,081 | ||
| Us-gaap_interestexpensenonoperating | 54,914 | - | ||
| Us-gaap_gainlossonderivativeinstrumentsnetpretax | 46,486 | - | ||
| Us-gaap_nonoperatingincomeexpense | -343,605 | - | ||
| Net loss | -724,643 | 231,236 | ||
| Us-gaap_netincomelossavailabletocommonstockholdersbasic | -724,643 | 231,236 | ||
| Diluted eps | - | - | ||
| Diluted average shares | - | 1,943,580,744 | ||
| Basic eps | - | - | ||
| Basic average shares | 681,000,979 | 566,665,842 | ||